Sponsors
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Research & Development
Increasing R&D efficiency from the bench up: a strategic look at simplifying laboratory operations
By Richard Lake, Pharmaceutical Market Development Manager, Restek Corporation
Pharma market in change
By Swiss Bioanalytics AG. All players in the pharmaceutical market are facing shared and individual challenges. The current situation is reflected from the view of a CRO providing core services for Bioanalysis.
Starting at phase zero
Michael Butler of Xceleron looks at the value a microdose study adds to a drug development programme.
Are blockbuster drugs dead in the water?
Reports suggest that blockbuster drugs - defined as a drug that generates more than $1 billion of revenue each year - are beginning to wane. Are the reports true? And if so, how can pharma shift its focus to compensate potentially massive losses?
Crisis, the opportunity
By Anabase International Corp. The current economic crisis is on everyone’s mind, even though the healthcare sector seems to be weathering the storm relatively well.
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.